ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

Duke’s Victor Dzau Named President of The Institute of Medicine

February 21, 2014

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Edward Harlow Named Recipient Of Bristol Award

March 29, 1991

VP Joe Biden Will Not Host Komen’s Global Race for the Cure in D.C.

May 11, 2012

Wilmot Researchers Study Combination for Lymphoma

September 26, 2003

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992